Suchergebnisse - "Weis, Nina"

PubPharm (6)

1

Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Jensen, S. | Fahnøe, U. | Pham, L. | +18

2

Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals : a clinical randomized study

enthalten in: European journal of gastroenterology & hepatology | 2018

von Sølund, C. | Andersen, E. | Mössner, B. | +10

3

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study

enthalten in: PloS one | 2017

von Dalgard, O. | Weiland, O. | Noraberg, G. | +14

4

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

enthalten in: BMC infectious diseases | 2017

von Young, J. | Weis, N. | Hofer, H. | +11

5

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection : a randomised study

enthalten in: Gut | 2015

von Hézode, C. | Hirschfield, G. | Ghesquiere, W. | +31

6

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection

enthalten in: Gastroenterology | 2015

von Dore, G. | Lawitz, E. | Hézode, C. | +24

1
[1]